Stanmore Implants

Stanmore Implants Worldwide Ltd. specializes in designing and manufacturing orthopedic implant systems for both juvenile and adult patients, with a focus on orthopedic oncology and complex primary and revision cases involving the upper limb, lower limb, and pelvis. The company offers a range of adult reconstructive solutions, including modular implant systems for the femur and knee, as well as patient-specific orthopedic oncology and extendible implants. For juvenile patients, Stanmore provides extendible prostheses that incorporate both minimally invasive and non-invasive solutions. The company is recognized for its innovative approaches, including the development of robotic bone preparation technology acquired through the purchase of Acrobot. Established in 1949 and headquartered in Elstree, United Kingdom, Stanmore operates as a subsidiary of Stryker Corporation, emphasizing its commitment to advancing limb-sparing and complex joint replacement solutions.